Literature DB >> 23550103

Anterior vitrectomy and partial capsulectomy via anterior approach to treat chronic postoperative endophthalmitis.

Mete Güler1, Turgut Yılmaz.   

Abstract

AIM: To describe the results of vitrectomy and partial capsulectomy via anterior approach surgical technique in treatment of chronic postoperative endophthalmitis (CPE).
METHODS: Clinical records of 9 patients treated for CPE between 2006 and 2010 were reviewed retrospectively. All of these patients were treated with vitrectomy and partial capsulectomy via anterior approach.
RESULTS: Six of 9 patients were male. The average patients' age was (60±8.1) years. The average period between cataract extraction and onset of signs and symptoms was (3.6±1.3) weeks. The average presenting visual acuity was 0.3±0.1 and the average final post operative visual acuity was 0.7±0.2. The mean follow-up period was (28.1±8.9) weeks. In all patients, the inflammation subsided after surgery.
CONCLUSION: Our results suggest that anterior vitrectomy and partial capsulectomy via anterior approach may be considered as potentially useful and relatively less invasive technique to treat CPE.

Entities:  

Keywords:  anterior vitrectomy; chronic postoperative endophthalmitis; partial capsulectomy

Year:  2013        PMID: 23550103      PMCID: PMC3580260          DOI: 10.3980/j.issn.2222-3959.2013.01.21

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  15 in total

1.  Improved detection of microorganisms by polymerase chain reaction in delayed endophthalmitis after cataract surgery.

Authors:  C P Lohmann; H J Linde; U Reischl
Journal:  Ophthalmology       Date:  2000-06       Impact factor: 12.079

2.  Propionibacterium acnes DNA from an explanted intraocular lens detected by polymerase chain reaction in a case of chronic pseudophakic endophthalmitis.

Authors:  Jui-Yang Lai; Ko-Hua Chen; Ying-Cheng Lin; Wen-Ming Hsu; Shui-Mei Lee
Journal:  J Cataract Refract Surg       Date:  2006-03       Impact factor: 3.351

3.  Propionibacterium acnes endophthalmitis diagnosed by microdissection and PCR.

Authors:  R R Buggage; D G Callanan; D F Shen; C C Chan
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

4.  Treatment strategies for postoperative Propionibacterium acnes endophthalmitis.

Authors:  A J Aldave; J D Stein; V A Deramo; G K Shah; D H Fischer; J I Maguire
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

5.  Lens capsular bag irrigation for low-grade endophthalmitis.

Authors:  Frank C Schlichtenbrede; Ulrich H M Spandau; Björn Harder; Jost B Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-04-24       Impact factor: 3.117

6.  [Nd-YAG capsulotomy and intravitreal antibiotics as treatment of chronic endophthalmitis].

Authors:  A Rojo; E Ferrer; C Torrón; M C Villuendas; O Ruiz; L Pablo; F M Honrubia
Journal:  Arch Soc Esp Oftalmol       Date:  2000-02

7.  Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis.

Authors:  W L Clark; P K Kaiser; H W Flynn; A Belfort; D Miller; D M Meisler
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

8.  Update of the management of postoperative endophthalmitis.

Authors:  J C S Yam; A K H Kwok
Journal:  Hong Kong Med J       Date:  2004-10       Impact factor: 2.227

9.  Growth curve for Propionibacterium acnes.

Authors:  G S Hall; K Pratt-Rippin; D M Meisler; J A Washington; T J Roussel; D Miller
Journal:  Curr Eye Res       Date:  1994-06       Impact factor: 2.424

10.  An epidemic of chronic pseudophakic endophthalmitis due to Ochrobactrum anthropi: clinical findings and managements of nine consecutive cases.

Authors:  Seung Song; Jae Kyoun Ahn; Gwang Hoon Lee; Yeoung Geol Park
Journal:  Ocul Immunol Inflamm       Date:  2007 Nov-Dec       Impact factor: 3.070

View more
  1 in total

1.  Persistently Vitreous Culture-Positive Exogenous Bacterial Endophthalmitis.

Authors:  Ella H Leung; Ajay E Kuriyan; Harry W Flynn; Darlene Miller; Laura C Huang
Journal:  Am J Ophthalmol       Date:  2016-02-26       Impact factor: 5.258

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.